Skip to main content
BAFN
NASDAQ Finance

BayFirst Q3 Loss Narrows to $0.7M; Material Weakness Persists

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Negative
Importance info
8
Price
$6.24
Mkt Cap
$193.881M
52W Low
$4.259
52W High
$9.5
52W Position info
47% above low
Off High info
34% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

BAFN sits 47% above its 52-week low of $4.259.

Summary

BayFirst's Q3 2026 loss narrowed to $0.7 million from $32.7 million in Q2, with margin up to 4.07%, but the material weakness in internal controls remains unremediated and disclosure controls were not effective. The $14.4 million rights offering closed October 8 at $3.50 per share.


Key Events · Earnings and Guidance · BAFN

  • Q3 Loss Narrows Sharply

    Net loss was $0.7 million, or $0.04 per share, versus $32.7 million in Q2 2026 and $19.1 million in Q3 2025.

  • Margin Expands to 4.07%

    Net interest margin rose to 4.07% in Q3 2026 from 3.48% in Q2 2026 and 3.64% in Q3 2025, as deposit costs fell.

  • Material Weakness Persists

    Management concluded internal control over financial reporting was not effective at September 30, 2026 due to the loan nonaccrual, charge-off and SBA gain-on-sale control weakness; disclosure controls were also not effective.

  • Rights Offering Closed

    4,107,908 common shares were sold at $3.50 per share on October 8, 2026 for gross proceeds of $14.4 million to bolster capital.


Analysis · BAFN · Finance

The headline improvement is real: the Q3 2026 10-Q shows the loss shrinking to $0.7 million from $32.7 million in Q2, while net interest margin climbed to 4.07% from 3.48%. What keeps the restatement overhang alive, however, is that the filing confirms the material weakness in internal controls over loan nonaccrual, charge-off and SBA gain-on-sale accounting remains unremediated, and disclosure controls were deemed not effective at September 30, 2026. Capital was rebuilt in the meantime, with the $14.4 million rights offering closing October 8 at $3.50 per share and Series C preferred being converted or redeemed by December 31, 2026. For the thesis, the control problem and the heavy share count expansion matter more than the quarter's improvement.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 47.7% of the 1624 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BAFN was trading at $6.24 on NASDAQ in the Finance sector, with a market capitalization of approximately $193.9M. The 52-week trading range was $4.26 to $9.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BAFN - Latest Insights

BAFN
Oct 29, 2026, 4:01 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $6.11
Real-time Price: $6.24 info
Change: +$0.130 (+2%) info
Market Cap: $193.881M info
BAFN
Oct 29, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.11
Real-time Price: $6.24 info
Change: +$0.130 (+2%) info
Market Cap: $193.881M info
BAFN
Oct 13, 2026, 4:26 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $5.20
Real-time Price: $6.24 info
Change: +$1.04 (+20%) info
Market Cap: $193.881M info
BAFN
Sep 01, 2026, 9:00 AM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $6.50
Real-time Price: $6.24 info
Change: -$0.260 (-4%) info
Market Cap: $193.881M info
BAFN
Aug 24, 2026, 10:05 AM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $6.24 info
Change: -$0.760 (-11%) info
Market Cap: $193.881M info